Literature DB >> 12768368

Doxycycline treatment in a model of early abdominal aortic aneurysm.

Keiko Kaito1, Hiroshi Urayama, Go Watanabe.   

Abstract

PURPOSE: To evaluate the effects doxycycline (Dox) in animal models of early abdominal aortic aneurysm.
METHODS: Of 43 male Wistar rats, 33 underwent intraluminal perfusion of the abdominal aorta with thioglycolate plus plasmin to reproduce early aortic aneurysm. These rats then were treated for 7 days with subcutaneous injections of Dox or saline. The 10 remaining rats underwent intra-aortic perfusion with saline and were injected subcutaneously with saline. On day 7, the rats were killed after abdominal aortic diameters were measured. Some aortic specimens were examined microscopically after elastica van Gieson (EVG) and hematoxylin-eosin (H&E) staining. In other specimens, the matrix metalloproteinase (MMP) activity in tissue extracts was evaluated by gelatin zymography.
RESULTS: Among the thioglycolate plus plasmin-perfused rats, the degree of aortic dilation was less in Dox-treated than in saline-treated rats. EVG staining indicated that Dox maintained a nearly normal pattern of elastic lamellae and normal medial elastin thickness. The aortic inflammatory response was not suppressed by Dox in H&E staining. In gelatin zymography, Dox reduced the MMP-9 activity, but did not significantly change either MMP-2 or the percentage of activated MMP-2.
CONCLUSIONS: Dox inhibited experimental aneurysmal dilation by preserving medial elastin. This effect involved the suppression of MMP-9 but not of the MMP-2 activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12768368     DOI: 10.1007/s10595-002-2513-0

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  16 in total

1.  A randomized controlled trial of subantimicrobial-dose doxycycline to prevent unscheduled bleeding with continuous oral contraceptive pill use.

Authors:  Bliss Kaneshiro; Alison Edelman; Nichole E Carlson; Mark Nichols; Marci Messerle Forbes; Jeffrey Jensen
Journal:  Contraception       Date:  2011-09-28       Impact factor: 3.375

2.  A failure of matrix metalloproteinase inhibition in the prevention of rat intracranial aneurysm formation.

Authors:  T J Kaufmann; W F Marx; D F Kallmes
Journal:  Neuroradiology       Date:  2006-01-04       Impact factor: 2.804

3.  Reduction of myocardial infarct size by doxycycline: a role for plasmin inhibition.

Authors:  Michael O Griffin; Miki Jinno; Lindsey A Miles; Francisco J Villarreal
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

4.  Development of a novel murine model of aortic aneurysms using peri-adventitial elastase.

Authors:  Castigliano M Bhamidipati; Gaurav S Mehta; Guanyi Lu; Christopher W Moehle; Carlos Barbery; Paul D DiMusto; Adriana Laser; Irving L Kron; Gilbert R Upchurch; Gorav Ailawadi
Journal:  Surgery       Date:  2012-08       Impact factor: 3.982

5.  Inhibition of transforming growth factor β worsens elastin degradation in a murine model of Kawasaki disease.

Authors:  Cristina M Alvira; Christophe Guignabert; Yu-Mee Kim; Chihhsin Chen; Lingli Wang; Trang T Duong; Rae S M Yeung; Dean Y Li; Marlene Rabinovitch
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

6.  Evolution of shear stress, protein expression, and vessel area in an animal model of arterial dilatation in hemodialysis grafts.

Authors:  Sanjay Misra; Alex A Fu; Khamal D Misra; James F Glockner; Debabrata Mukhopadyay
Journal:  J Vasc Interv Radiol       Date:  2010-01       Impact factor: 3.464

Review 7.  Aortic Wall Inflammation in the Pathogenesis, Diagnosis and Treatment of Aortic Aneurysms.

Authors:  Georgia Skotsimara; Alexios Antonopoulos; Evangelos Oikonomou; Charalampos Papastamos; Gerasimos Siasos; Dimitrios Tousoulis
Journal:  Inflammation       Date:  2022-01-25       Impact factor: 4.092

Review 8.  Cysteine protease cathepsins and matrix metalloproteinases in the development of abdominal aortic aneurysms.

Authors:  Yanwen Qin; Xu Cao; Yaoguo Yang; Guo-Ping Shi
Journal:  Future Cardiol       Date:  2013-01

9.  SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis.

Authors:  Nesrine El-Bizri; Christophe Guignabert; Lingli Wang; Alexander Cheng; Kryn Stankunas; Ching-Pin Chang; Yuji Mishina; Marlene Rabinovitch
Journal:  Development       Date:  2008-07-30       Impact factor: 6.868

Review 10.  Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm.

Authors:  Faisal Aziz; Helena Kuivaniemi
Journal:  Ann Vasc Surg       Date:  2007-05       Impact factor: 1.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.